# Antecedent Metabolic Health and Metformin Aging Study

> **NCT04264897** · PHASE3 · COMPLETED · sponsor: **Oklahoma Medical Research Foundation** · enrollment: 101 (actual)

## Conditions studied

- Aging
- Insulin Sensitivity
- Chronic Disease
- Mitochondria
- Insulin Resistance

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04264897
- **Lead sponsor:** Oklahoma Medical Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-29
- **Primary completion:** 2025-03-12
- **Final completion:** 2025-03-12
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264897, "Antecedent Metabolic Health and Metformin Aging Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04264897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*